These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1590685)

  • 1. Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.
    Tawara S; Matsumoto S; Kamimura T; Goto S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):17-24. PubMed ID: 1590685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of cefpirome, a new cephalosporin, on various models of infections in mice and rats.
    Arai S; Kobayashi S; Hayashi S
    Jpn J Antibiot; 1990 Jan; 43(1):1-8. PubMed ID: 2190011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
    Palmer SM; Kang SL; Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1764-71. PubMed ID: 7486916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Vree TB; Baars AM; Michel MF
    Antimicrob Agents Chemother; 1985 Nov; 28(5):654-9. PubMed ID: 3911879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1980 Oct; 18(4):549-56. PubMed ID: 7004342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models.
    Miyazaki S; Okazaki K; Tsuji M; Yamaguchi K
    Antimicrob Agents Chemother; 2004 Feb; 48(2):378-83. PubMed ID: 14742183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.
    Wang H; Yu Y; Xie X; Wang C; Zhang Y; Yuan Y; Zhang X; Liu J; Wang P; Chen M
    J Infect Chemother; 2000 Jun; 6(2):81-5. PubMed ID: 11810540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of in vitro antibacterial activities of cefotiam and cefazolin to their therapeutic effects on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
    Nishi T; Nakao M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Feb; 34(2):231-9. PubMed ID: 6271719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
    Yokota T; Yoshida R; Utsui Y; Tajima M
    Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.
    Steckelberg JM; Rouse MS; Tallan BM; Osmon DR; Henry NK; Wilson WR
    Antimicrob Agents Chemother; 1993 Mar; 37(3):554-8. PubMed ID: 8460924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
    Iizawa Y; Okonogi K; Hayashi R; Iwahi T; Yamazaki T; Imada A
    Antimicrob Agents Chemother; 1993 Jan; 37(1):100-5. PubMed ID: 8431004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.